These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26661169)

  • 21. Small molecule inhibitors in the treatment of cerebral ischemia.
    Flores JJ; Zhang Y; Klebe DW; Lekic T; Fu W; Zhang JH
    Expert Opin Pharmacother; 2014 Apr; 15(5):659-80. PubMed ID: 24491068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
    Schmidt A; Minnerup J; Kleinschnitz C
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute stroke therapy: translating preclinical neuroprotection to therapeutic reality.
    Parsons AA; Irving EA; Legos JJ; Lenhard SC; Chandra S; Schaeffer TR; Haimbach RE; White RF; Hunter AJ; Barone FC
    Curr Opin Investig Drugs; 2000 Dec; 1(4):452-63. PubMed ID: 11249699
    [No Abstract]   [Full Text] [Related]  

  • 24. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.
    Morales JR; Ballesteros I; Deniz JM; Hurtado O; Vivancos J; Nombela F; Lizasoain I; Castrillo A; Moro MA
    Circulation; 2008 Sep; 118(14):1450-9. PubMed ID: 18794391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.
    Chang L; Chen Y; Li J; Liu Z; Wang Z; Chen J; Cao W; Xu Y
    Brain Behav Immun; 2011 Feb; 25(2):260-9. PubMed ID: 20869431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ELR-CXC chemokine antagonism is neuroprotective in a rat model of ischemic stroke.
    Connell BJ; Gordon JR; Saleh TM
    Neurosci Lett; 2015 Oct; 606():117-22. PubMed ID: 26320021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvianolic acid B attenuates apoptosis and inflammation via SIRT1 activation in experimental stroke rats.
    Lv H; Wang L; Shen J; Hao S; Ming A; Wang X; Su F; Zhang Z
    Brain Res Bull; 2015 Jun; 115():30-6. PubMed ID: 25981395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
    Thériault P; Le Béhot A; ElAli A; Rivest S
    Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotection in stroke: the importance of collaboration and reproducibility.
    Neuhaus AA; Couch Y; Hadley G; Buchan AM
    Brain; 2017 Aug; 140(8):2079-2092. PubMed ID: 28641383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role of myo-inositol to improve ischemic stroke outcome in diabetic mouse.
    Villalba H; Shah K; Albekairi TH; Sifat AE; Vaidya B; Abbruscato TJ
    Brain Res; 2018 Nov; 1699():166-176. PubMed ID: 30165043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRIMED
    Bahr-Hosseini M; Bikson M; Iacoboni M; Liebeskind DS; Hinman JD; Carmichael ST; Saver JL
    Transl Stroke Res; 2022 Apr; 13(2):222-227. PubMed ID: 34196953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
    Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
    Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice.
    Alawieh A; Langley EF; Tomlinson S
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation as a therapeutic target in acute ischemic stroke treatment.
    Tuttolomondo A; Di Sciacca R; Di Raimondo D; Renda C; Pinto A; Licata G
    Curr Top Med Chem; 2009; 9(14):1240-60. PubMed ID: 19849665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthotoxol exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia.
    He W; Chen W; Zhou Y; Tian Y; Liao F
    Cell Mol Neurobiol; 2013 Jul; 33(5):715-22. PubMed ID: 23619720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between the induction of inflammatory processes and infectious diseases in patients with ischemic stroke.
    Cieślak M; Wojtczak A; Cieślak M
    Acta Biochim Pol; 2013; 60(3):345-9. PubMed ID: 24046817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystamine improves functional recovery via axon remodeling and neuroprotection after stroke in mice.
    Li PC; Jiao Y; Ding J; Chen YC; Cui Y; Qian C; Yang XY; Ju SH; Yao HH; Teng GJ
    CNS Neurosci Ther; 2015 Mar; 21(3):231-40. PubMed ID: 25430473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain.
    Wu KJ; Yu SJ; Shia KS; Wu CH; Song JS; Kuan HH; Yeh KC; Chen CT; Bae E; Wang Y
    Cell Transplant; 2017 Apr; 26(4):571-583. PubMed ID: 27938478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment.
    Yang L; Islam MR; Karamyan VT; Abbruscato TJ
    Brain Res; 2015 Jun; 1609():1-11. PubMed ID: 25801116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.